Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2026)
Orthopediatrics (KIDS) posted quarterly Total Non-Current Liabilities of $116.3 million for Q1 2026, up 35.86% year-over-year from $85.6 million in Q1 2025, and little changed quarter-over-quarter from $115.8 million in Q4 2025.
Orthopediatrics (KIDS) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has reported Total Non-Current Liabilities for 9 consecutive years, with $116.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 35.86% year-over-year to $116.3 million; the TTM figure through Mar 2026 stood at $116.3 million (up 35.86% YoY), while the FY2025 annual figure was $115.8 million, up 36.79% from the prior year.
- Total Non-Current Liabilities was little changed at $116.3 million in Q1 2026 per KIDS's latest filing, from $115.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $116.3 million in Q1 2026 and bottomed at $10.2 million in Q3 2023.
- Historically, Total Non-Current Liabilities has averaged $56.8 million across 5 years, with a median of $51.6 million in 2022.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities slumped 85.87% — and 2024, when it surged 722.05%.
- Orthopediatrics' Total Non-Current Liabilities stood at $18.2 million in 2022, then climbed by 10.14% to $20.1 million in 2023, then surged by 322.26% to $84.7 million in 2024, then surged by 36.79% to $115.8 million in 2025, then advanced by 0.4% to $116.3 million in 2026.
- Business Quant data shows KIDS's Total Non-Current Liabilities at $116.3 million in Q1 2026, $115.8 million in Q4 2025, and $110.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Orthopediatrics | 631.76 Mn | 585.88 Mn | 52.37 Mn | 114.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 114.92 Mn |
| Mar 31, 2026 | 116.30 Mn |
| Dec 31, 2025 | 115.84 Mn |
| Sep 30, 2025 | 110.95 Mn |
| Jun 30, 2025 | 109.43 Mn |
| Mar 31, 2025 | 85.60 Mn |
| Dec 31, 2024 | 84.68 Mn |
| Sep 30, 2024 | 83.75 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 20.78 Mn |
| Dec 31, 2023 | 20.05 Mn |
| Sep 30, 2023 | 10.19 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Mar 31, 2023 | 17.92 Mn |
| Dec 31, 2022 | 18.21 Mn |
| Sep 30, 2022 | 17.98 Mn |
| Jun 30, 2022 | 72.51 Mn |
| Mar 31, 2022 | 51.62 Mn |
| Dec 31, 2021 | 49.19 Mn |
| Sep 30, 2021 | 54.46 Mn |